Evidence of in vivo differential bioavailability of the active forms of matrix metalloproteinases 9 and 2 in parturition, spontaneous rupture of membranes, and intra-amniotic infection
Article Abstract:
Levels of the enzyme matrix metalloproteinase-9 increase in amniotic fluid during the rupture of fetal membranes and also during uterine infection. This enzyme breaks down fetal membranes.
Publication Name: American Journal of Obstetrics and Gynecology
Subject: Health
ISSN: 0002-9378
Year: 2000
User Contributions:
Comment about this article or add new information about this topic:
Lactoferrin in intrauterine infection, human parturition, and rupture of fetal membranes
Article Abstract:
Levels of lactoferrin in amniotic fluid increase when the uterus becomes infected, according to a study of 268 pregnant women. Lactoferrin is a protein in amniotic fluid that transports iron, and it is known to have antibacterial properties.
Publication Name: American Journal of Obstetrics and Gynecology
Subject: Health
ISSN: 0002-9378
Year: 2000
User Contributions:
Comment about this article or add new information about this topic:
Participation of hte novel cytokine interleukin 18 in the host response to intra-amniotic infection
Article Abstract:
The production of interleukin-18 is increased in pregnant women who have an intra-uterine infection, according to a study of 285 pregnant women. Interleukin-18 is a pro-inflammatory substance produced by the immune system that is believed to protect humans from infection.
Publication Name: American Journal of Obstetrics and Gynecology
Subject: Health
ISSN: 0002-9378
Year: 2000
User Contributions:
Comment about this article or add new information about this topic:
- Abstracts: Human neutrophil collagenase (matrix metalloproteinase 8) in parturition, premature rupture of the membranes, and intrauterine infection
- Abstracts: Effect of oral iodized oil on thyroid size and thyroid hormone metabolism in children with concurrent selenium and iodine deficiency
- Abstracts: Role of amnioinfusion in the management of premature rupture of the membranes at less than 26 weeks' gestation